Viewing Study NCT05775900


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2026-06-21 @ 4:58 PM
Study NCT ID: NCT05775900
Status: COMPLETED
Last Update Posted: 2025-09-03
First Post: 2023-02-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
Sponsor:
Organization: